“India’s Low-Income Hearts at Risk as Affordable Semaglutide Expands”
A life-saving drug for heart attacks is becoming more accessible in India, but millions are being priced out due to outdated BMI guidelines. The patent on semaglutide, a proven heart attack prevention medication, expires soon, making generic versions cheaper by 90%. However, the current eligibility criteria set by the FDA in the US don’t apply … Read more